These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12126317)

  • 21. Expectations for tPA is pathway to litigation.
    ED Manag; 2011 Feb; 23(2):18-9. PubMed ID: 21400969
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Teoh HL; Chan BP
    Expert Rev Neurother; 2012 Feb; 12(2):209-17. PubMed ID: 22288676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should more patients with acute ischaemic stroke receive thrombolytic treatment?
    Wardlaw JM; Sandercock PA; Murray V
    BMJ; 2009 Nov; 339():b4584. PubMed ID: 19906748
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
    Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
    Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Right brain: my first tPA.
    Robbins MS
    Neurology; 2009 Jul; 73(2):e9-e10. PubMed ID: 19597130
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thrombolytic therapy for acute ischemic stroke].
    Mori E
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():33-7. PubMed ID: 17469531
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
    [No Abstract]   [Full Text] [Related]  

  • 31. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
    Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
    Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteplase for acute stroke revisited: the first 10 years.
    Lyden PD; Lees KR; Davis SM
    Lancet Neurol; 2006 Sep; 5(9):722-4. PubMed ID: 16914399
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
    Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
    N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era.
    Chalela JA; Kang DW; Luby M; Ezzeddine M; Latour LL; Todd JW; Dunn B; Warach S
    Ann Neurol; 2004 Jan; 55(1):105-12. PubMed ID: 14705118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
    Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
    Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
    [No Abstract]   [Full Text] [Related]  

  • 36. Tissue plasminogen activator approved for stroke.
    Barber A; Gommans J
    N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
    [No Abstract]   [Full Text] [Related]  

  • 37. Missing the point (estimate)? Confidence intervals for the number needed to treat.
    Barrowman NJ
    CMAJ; 2002 Jun; 166(13):1676-7. PubMed ID: 12126323
    [No Abstract]   [Full Text] [Related]  

  • 38. Age and Stroke Severity: Hazards for Intravenous Thrombolysis?
    Long C; Li M
    Med Princ Pract; 2016; 25(1):99-100. PubMed ID: 26457894
    [No Abstract]   [Full Text] [Related]  

  • 39. A FAST lesson in stroke treatment.
    Taylor B
    Tex Dent J; 2013 Jun; 130(6):494-6. PubMed ID: 24195189
    [No Abstract]   [Full Text] [Related]  

  • 40. Truths about the NINDS study: setting the record straight.
    Mann J
    West J Med; 2002 May; 176(3):192-4. PubMed ID: 12016245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.